High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies (2022)
- Authors:
- Autor USP: SHINJO, SAMUEL KATSUYUKI - FM
- Unidade: FM
- DOI: 10.1007/s10067-022-06270-4
- Subjects: PREVALÊNCIA; MIOSITE; DERMATOPATIAS; BIÓPSIA POR AGULHA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical rheumatology
- ISSN: 0770-3198
- Volume/Número/Paginação/Ano: v. 41, n. 11, p. 3411-3417, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CAETANO, Aline Marques et al. High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies. Clinical rheumatology, v. 41, n. 11, p. 3411-3417, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50416. Acesso em: 10 fev. 2026. -
APA
Caetano, A. M., Borges, I. B. P., Silva, L. M. B. da, & Shinjo, S. K. (2022). High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies. Clinical rheumatology, 41( 11), 3411-3417. doi:10.1007/s10067-022-06270-4 -
NLM
Caetano AM, Borges IBP, Silva LMB da, Shinjo SK. High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies [Internet]. Clinical rheumatology. 2022 ; 41( 11): 3411-3417.[citado 2026 fev. 10 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50416 -
Vancouver
Caetano AM, Borges IBP, Silva LMB da, Shinjo SK. High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies [Internet]. Clinical rheumatology. 2022 ; 41( 11): 3411-3417.[citado 2026 fev. 10 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50416 - Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
- Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study
- Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis
- Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
- Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study
- Cardiovascular manifestations in idiopathic inflammatory myopathies
- Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
- Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study
- Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis
- COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis
Informações sobre o DOI: 10.1007/s10067-022-06270-4 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
